000 | 01953ngm a2200361 a 4500 | ||
---|---|---|---|
001 | HST1264_1_2 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 080121s2007 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a1264 _bHenry Stewart Talks |
035 | _a(UkLoHST)595 | ||
035 | _a(UkLU-K)AC000390470 | ||
040 |
_aUkLU-K _beng _cUkLU-K |
||
100 | 1 |
_aCompston, Alastair. _4spk |
|
245 | 1 | 0 |
_aAntibody therapy of multiple sclerosis _h[electronic resource] / _cAlastair Compston & Alasdair Coles. |
260 |
_aLondon : _bHenry Stewart Talks, _c2007. |
||
300 |
_a1 online resource (1 streaming video file (48 min.) : _bcolor, sound). |
||
490 | 1 |
_aMonoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: The story of multiple sclerosis -- Symptoms -- Pathogenesis -- Pathological heterogeneity -- Axonal degeneration -- Current treatments -- Interferons and glatiramer -- Monoclonal antibody treatment of multiple sclerosis -- Daclizumab -- Natalizumab -- The story of Campath-1H -- The effect of Campath-1H on disability depends upon the stage of the disease -- Graves' disease -- Immune thrombocytopenia -- Future treatment of multiple sclerosis. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 2 |
_aAntibodies, Monoclonal _xtherapeutic use. |
|
650 | 2 |
_aMultiple Sclerosis _xtherapy. |
|
650 | 2 | _aMultiple Sclerosis. | |
700 | 1 |
_aColes, Alasdair. _4spk |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pMonoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/595/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/30/ _3Series |
999 |
_c77933 _d77933 |